Extended Pembrolizumab Duration Tied to Lower Mortality in Stage III and IV Melanoma: JDD Report Could extending pembrolizumab improve survival? This JDD is a must read. A new retrospective analysis…
Read More
Check Out JDD Corner’s Latest Author Spotlight Our current Author Spotlight features Brooke Bartley MD, one of the co-authors of Efficacy and Safety of Cosibelimab for Advanced Cutaneous Squamous Cell…
Read More
Melanoma on the Rise: Are We Keeping Pace With Detection and Care? Melanoma, particularly cutaneous melanoma, is becoming an increasingly prevalent problem in the United States (US). It is currently…
Read More
JDD alert: Must-read study reports an association between lichen planopilaris and scalp non-melanoma skin cancer A new JDD report analyzes global TriNetX data from 2005 to 2025 and compares patients…
Read More
Survey reveals higher likelihood of reported delays in accessing melanoma care among patients with skin of color Have you read one of the latest articles published in JDD titled, “Delays…
Read More
From the Vault: In this article from JDD, a multi state BRFSS analysis finds higher skin cancer history in rural populations and In this article from the JDD vault, authors…
Read More
From the Vault: Noninvasive RNA from Tape Strips Differentiates AK from SCC In this article from the JDD vault, authors report a single center study that used adhesive tape strips…
Read More
From the Vault: Fecal transplant may revive immunotherapy responses in melanoma We pulled this February 2024 vault article because it’s been a popular read. It’s a focused review of microbiota‑modulating…
Read More
From the Vault: Fecal microbiota transplant may revive ICI responses in metastatic melanoma We went into the JDD vault to highlight a focused review of microbiota‑modulating interventions in metastatic melanoma treated…
Read More
Mohs proves highly effective for female genital skin cancers - pooled review reports ~95% cure A targeted systematic review of the literature identified 166 treated cases of extramammary Paget’s disease,…
Read More
Neoadjuvant Hedgehog Inhibitors: Gaining Ground in Mohs for BCC? A recent survey of American College of Mohs Surgery members reveals that 22% of Mohs surgeons are already using hedgehog pathway…
Read More
Researchers at NYU Langone Health and the Perlmutter Cancer Center have discovered why many patients with melanoma are resistant to current treatments and how an existing drug class is effective…
Read More
